​Thank you for your inquiry for CMS130v10 (2022 Performance Period), Colorectal Cancer Screening. The eCQM does not require information about the location or performer of the FOBT, or 'where the test is read'. The measure criteria for FOBT can be met if the patient had an FOBT laboratory test of any result performed during the measurement period, as documented by electronic health record data. Specific types of FOBT are defined in the eCQM specifications (CMS130v10 eCQM Human-Readable HTML Format: https://ecqi.healthit.gov/sites/default/files/ecqm/measures/CMS130v10.html) . They include any of the LOINC codes listed in the following value set ‘Fecal Occult Blood Test (FOBT), such as LOINC 2335-8 (Hemoglobin.gastrointestinal [Presence] in Stool): https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.198.12.1011/expansion/eCQM%20Update%202021-05-06 . For more information about the measure specification, please see additional resources for reference: - CMS130v10 Specifications: https://ecqi.healthit.gov/ecqm/ep/2022/cms130v10 - eCQI Resource Center – Guide for Reading eCQMs Version 7.0 May 2021: https://ecqi.healthit.gov/sites/default/files/Guide-for-Reading-eCQMs-v7.pdf

A practice wrote in asking if, for an FOBT, whether the test needs to be read by a laboratory or if the testing card and be read by a clinician in a physician's office? There is no specific guidance regarding where the test is read and specific type of FOBT, can you advise?